我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Short Course Hypofractionation- Palliative Radiation Regimen in Squamous Cell Carcinoma of Head and Neck

Pramila Kumari

Aim: To evaluate the role of short course hypo-fractionated radiotherapy regimen in patients of locally advanced head and neck cancer(LAHNC)of advanced stage for symptomatic relief.In Indian setting, more than 70% patients present in locally advanced stage and with poor general condition and are suitable candidates for palliative radiotherapy. This is a prospective pilot study of a Regional cancer institute of North west zone. Materials and Methods:36 patients with stage 3 and stage 4, head and neck cancer were treated with a short course of palliative radiotherapy [30 Gray (Gy)] in 10 fractions over 2 weeks). Baseline symptoms were assessed before the start of study for pain, dysphagia, respiratory symptoms, anxiety/depression and dyspnoea. First assessment for symptom relief was done at the completion of radiotherapy and then between 3 to 4 weeks aftercompletion ofradiotherapy. Results: In the present study, out of total 36 patients, 72.22% were males and 27.78% were females and Median Karnofsky score was 60. Most common site was oropharynx in 14 (40%) patients followed by larynx was involved in 9 (24%) patients, hypopharynx was involved in 7 (17%) patients. 11 (31%) patients were found to be in stage III and 25 (69%) patients were found to be in stage IV of carcinoma. After completion of radiotherapy course and 3-4 weeks follow up, 88% patients had pain relief, 83% shown improvement in dysphagia, 81% patients shown improved sleep patterns and 65% improvement in respiratory symptoms. 75% patients had betterment in dysphonia. In 23 (65%) patients, Grade-I Mucositis was seen, 13 (35%) patients shown Grade-II mucositis, 15 (44%) patients had Grade-I skin toxicity and Grade-II skin toxicity was seen in 21 (56%) patients. Conclusion:A short course of radiation promises to effectively relieve symptoms in locally advanced head and neck cancers and reduce the need of ongoing analgesic therapy and hospital visits. It reduces the need of continued supportive care and overall improves quality of patients' life. Reduces patients’ frequent visits to hospital.